Home  |  Contact

UniProtKB/Swiss-Prot Q13315: Variant p.Ser2855Arg

Serine-protein kinase ATM
Gene: ATM
Feedback?
Variant information Variant position: help 2855 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Arginine (R) at position 2855 (S2855R, p.Ser2855Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AT; unknown pathological significance. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 2855 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 3056 The length of the canonical sequence.
Location on the sequence: help CMEKFLDPAIWFEKRLAYTR S VATSSIVGYILGLGDRHVQN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CMEKFLDPAIWFEKRLAYTRSVATSSIVGYILGLGDRHVQN

Mouse                         CMEKFLDPAVWFEKRLAYTRSVATSSIVGYILGLGDRHVQN

Pig                           CMEKFLDPAVWFERRLAYTQSVATSSIVGYILGLGDRHVQN

Caenorhabditis elegans        FYTNFSTAQIWRQKIINYRQSLATWSIVCYIVGLGDRHASN

Drosophila                    LLEKFPIPGVWFERRLAYTNSVATTSMVGYVLGLGDRHTQN

Baker's yeast                 FFDSFPDPLDWFEAKKTYTKGVAASSIVGYILGLGDRHLNN

Fission yeast                 FLESYADPVQWFTTQTNYARSTAVASVLGHVLGLGDRHGQN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 3056 Serine-protein kinase ATM
Domain 2686 – 2998 PI3K/PI4K catalytic
Mutagenesis 2870 – 2870 D -> A. Loss of kinase activity.
Mutagenesis 2875 – 2875 N -> K. Loss of kinase activity.
Helix 2842 – 2866



Literature citations
New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy.
Castellvi-Bel S.; Sheikhavandi S.; Telatar M.; Tai L.-Q.; Hwang M.J.; Wang Z.; Yang Z.; Cheng R.; Gatti R.A.;
Hum. Mutat. 14:156-162(1999)
Cited for: VARIANTS AT CYS-49; 375-GLN--VAL-3056 DEL; 1466-ARG--VAL-3056 DEL; 1730-ARG--VAL-3056 DEL; GLY-2016; 2224-MET--ARG-2227 DELINS ILE-SER; 2246-CYS--THR-2252 DELINS HIS; VAL-2664 DEL; VAL-2726; 2849-ARG--VAL-3056 DEL AND ARG-2855;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.